Skip to content
HowShorted

Acurx Pharmaceuticals, Inc. short interest in 2025

In 2025, Acurx Pharmaceuticals, Inc.'s disclosed short interest ran from 3.88% of shares outstanding on 15 Jan 2025 to 3.87% on 31 Dec 2025, a change of -0.01 percentage points. The year's high was 3.88% on 15 Jan 2025 and its low 1.26% on 14 Feb 2025, averaging 2.33% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.18 days on 30 Apr 2025. Full history: Acurx Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Acurx Pharmaceuticals, Inc. in 2025

2025 in figures

Start of year
3.88% (15 Jan 2025)
End of year
3.87% (31 Dec 2025)
Change
-0.01 pp
High
3.88% (15 Jan 2025)
Low
1.26% (14 Feb 2025)
Average
2.33%
Highest days to cover
3.18 (30 Apr 2025)
SEC filings marked
6

Every report in 2025

Acurx Pharmaceuticals, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20253.88%1.00
31 Jan 20251.85%1.41
14 Feb 20251.26%2.77
28 Feb 20252.68%1.00
14 Mar 20252.51%1.44
31 Mar 20252.16%2.8410-K filed, results (8-K)
15 Apr 20251.90%2.63
30 Apr 20251.60%3.18
15 May 20251.74%2.1810-Q filed, results (8-K)
30 May 20251.34%1.30
13 Jun 20252.39%2.08
30 Jun 20252.98%1.00
15 Jul 20252.90%1.00
31 Jul 20252.45%1.00
14 Nov 20251.75%1.0010-Q filed, 10-Q filed
31 Dec 20253.87%1.47

See also: Acurx Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.